TriSalus Life Sciences (TLSIW) Amortizatization of Intangibles (2023 - 2026)
TriSalus Life Sciences (TLSIW) reported Amortizatization of Intangibles of $31000.0 for Q1 2026, down 82.08% on a YoY basis from $173000.0 in Q1 2025, and up 40.91% quarter-over-quarter from $22000.0 in Q4 2025.
TriSalus Life Sciences (TLSIW) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
TriSalus Life Sciences has reported Amortizatization of Intangibles for 4 years, with the latest figure at $31000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 82.08% year-over-year to $31000.0; the trailing twelve-month figure through Mar 2026 stood at $287000.0 (down 20.5% YoY), and the FY2025 full-year result was $429000.0, up 62.5% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $31000.0, up from $22000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $411000.0 in Q2 2025, with the low at -$177000.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $77166.7 across 4 years, with a median of $53000.0 in 2024.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles jumped 781.82% — and 2025, when it plunged 315.85%.
- TriSalus Life Sciences' Amortizatization of Intangibles stood at $202000.0 in 2023, then sank by 84.65% to $31000.0 in 2024, then declined by 29.03% to $22000.0 in 2025, then soared by 40.91% to $31000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $31000.0 (Q1 2026), $22000.0 (Q4 2025), and -$177000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | 31,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | -177,000.00 |
| Sep 30, 2025 | -177,000.00 |
| Jun 30, 2025 | 411,000.00 |
| Jun 30, 2025 | 411,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 75,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Dec 31, 2023 | 202,000.00 |